LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Reset all filters
01 1LGM Pharma
02 1HRV Pharma
03 1Pharmathen SA
04 1Enaltec Labs
05 1Fareva
06 1Vital Laboratories Private Limited
07 1Ajanta Pharma Limited
08 1Amara Labs
09 1Anthem Biosciences
10 1Apotex Pharmachem
11 1Arene Lifesciences
12 1Aspire Lifesciences Pvt Ltd
13 1Aurobindo Pharma Limited
14 1Aurore Life Sciences
15 1Calyx Chemicals & Pharmaceuticals
16 3Charioteer
17 1Cipla
18 1CordenPharma
19 1DEAFARMA
20 1Dasami Lab
21 1Dishman Carbogen Amcis
22 1Guangzhou Tosun Pharmaceutical
23 2Hetero Drugs
24 1Hubei Gedian Humanwell Pharmaceutical
25 1MSN Laboratories
26 1Maithili Life Sciences
27 1Matrix Pharmaceutical Inc
28 4Olon S.p.A
29 1Rakshit Drugs
30 1Shanghai Pharma Group
31 1Shouyuan Chemical
32 1Srini Pharmaceuticals
33 2Sun Pharmaceutical Industries Limited
34 1Synthimed Labs
35 1Tecoland Corporation
36 1Tianish Laboratories
37 2Viatris
Reset all filters
01 1Canada
02 7China
03 1Germany
04 1Greece
05 24India
06 5Italy
07 1Luxembourg
08 5U.S.A
Reset all filters
01 17Active
02 5Inactive
03 23Blank
01 7Valid
02 38Blank
Reset all filters
01 45Blank
Reset all filters
01 1WC-0023
02 1WC-003
03 1WC-0118
04 1WC-0144
05 41Blank
Reset all filters
01 45Blank
Reset all filters
01 112869-038
02 117337-0040
03 117337-0084
04 117337-0320
05 117337-0327
06 161876-0072
07 163310-2410
08 165862-756
09 165977-0070
10 166639-010
11 169875-8044
12 170966-0037
13 171666-008
14 172761-029
15 184206-0098
16 30Blank
01 45Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
GDUFA
DMF Review : Reviewed
Rev. Date : 2025-09-26
Pay. Date : 2025-08-21
DMF Number : 42083
Submission : 2025-06-25
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2021-03-24
Pay. Date : 2020-12-29
DMF Number : 34600
Submission : 2020-02-26
Status : Active
Type : II
Certificate Number : CEP 2023-375 - Rev 00
Issue Date : 2024-12-17
Type : Chemical
Substance Number : 2930
Status : Valid
NDC Package Code : 72761-029
Start Marketing Date : 2021-05-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2022-10-13
Pay. Date : 2021-09-29
DMF Number : 35107
Submission : 2021-09-19
Status : Active
Type : II
Certificate Number : CEP 2024-326 - Rev 00
Issue Date : 2025-11-21
Type : Chemical
Substance Number : 2930
Status : Valid
NDC Package Code : 69875-8044
Start Marketing Date : 2021-07-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30023
Submission : 2015-11-12
Status : Active
Type : II
NDC Package Code : 12869-038
Start Marketing Date : 2001-03-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

71
PharmaCompass offers a list of Valganciclovir Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Valganciclovir Hydrochloride manufacturer or Valganciclovir Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Valganciclovir Hydrochloride manufacturer or Valganciclovir Hydrochloride supplier.
PharmaCompass also assists you with knowing the Valganciclovir Hydrochloride API Price utilized in the formulation of products. Valganciclovir Hydrochloride API Price is not always fixed or binding as the Valganciclovir Hydrochloride Price is obtained through a variety of data sources. The Valganciclovir Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Valcyte manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Valcyte, including repackagers and relabelers. The FDA regulates Valcyte manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Valcyte API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Valcyte manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Valcyte supplier is an individual or a company that provides Valcyte active pharmaceutical ingredient (API) or Valcyte finished formulations upon request. The Valcyte suppliers may include Valcyte API manufacturers, exporters, distributors and traders.
click here to find a list of Valcyte suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 37 companies offering Valcyte
Get in contact with the supplier of your choice: